Mubashir Ahmad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mubashir Ahmad has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
- Jan Tuckermann
Institute of Comparative Molecular Endocrinology, Ulm University, Ulm, Baden-Württemberg, Germany
12 shared publications - Anita Ignatius
Institute of Orthopedic Research and Biomechanics, Ulm University Medical Center, Germany
9 shared publications Aspasia Ploubidou
Leibniz Institute on Aging – Fritz Lipmann Institute (FLI), Jena, Germany
4 shared publications- Melanie Haffner-Luntzer
Institute of Orthopedic Research and Biomechanics, University Medical Center Ulm, Ulm, Germany
4 shared publications Anita Ignatius
Institute of Orthopedic Research and Biomechanics, Ulm, Germany
3 shared publicationsAnn-Kristin Dorn
Institute of Molecular Endocrinology and Physiology, Ulm University, Ulm, Germany
3 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1967862
Glucocorticoid receptor regulates osteoblast differentiation in association with Map7d2 and Erk2 signaling
The glucocorticoid receptor (GR) is an important regulator of skeletal homeostasis; however, the molecular mechanisms through which it regulates osteogenic differentiation remain incompletely understood. Here, we investigated the role of GR using two complementary primary murine osteogenic cell models, bone marrow stromal cells (BMSCs) and bone-derived primary osteoblasts, together with comparative transcriptomic analyses. GR depletion significantly impaired osteogenic differentiation in both cell preparations, as demonstrated by reduced alkaline phosphatase (Alp) activity and altered expression of osteogenic markers. RNA sequencing (RNA-seq) revealed extensive transcriptional changes following GR knockdown, with 3,530 differentially expressed genes (DEGs) in BMSCs and 4,657 in primary osteoblasts. Despite substantial differences in gene expression profiles of the two osteogenic cell models, pathway enrichment analyses revealed common biological processes, including MAPK signaling and cell migration. Comparative transcriptomic analysis further identified only 17 genes that were consistently regulated in the same direction in both cell preparations, among which Map7d2 emerged as a previously unrecognized GR-responsive candidate. Combined depletion of GR and Map7d2 partially restored cellular Alp activity and the expression of selected osteogenic markers compared with GR depletion alone. Western blot analysis further showed restoration of Erk2 phosphorylation and Alp protein expression following combined GR and Map7d2 depletion, demonstrating an association between the partial rescue of selected osteogenic readouts and restoration of Erk2 signaling. Together, these findings identify Map7d2 as a previously unrecognized GR-responsive candidate associated with Erk2 signaling and osteogenic differentiation. Our study reveals common molecular responses to GR depletion across two primary murine osteogenic cell models and provides new insights into the transcriptional and signaling networks underlying GR-regulated osteogenic differentiation.
- 29 October 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1967862
Open AccessGlucocorticoid receptor regulates osteoblast differentiation in association with Map7d2 and Erk2 signaling
The glucocorticoid receptor (GR) is an important regulator of skeletal homeostasis; however, the molecular mechanisms through which it regulates osteogenic differentiation remain incompletely understood. Here, we investigated the role of GR using two complementary primary murine osteogenic cell models, bone marrow stromal cells (BMSCs) and bone-derived primary osteoblasts, together with comparative transcriptomic analyses. GR depletion significantly impaired osteogenic differentiation in both cell preparations, as demonstrated by reduced alkaline phosphatase (Alp) activity and altered expression of osteogenic markers. RNA sequencing (RNA-seq) revealed extensive transcriptional changes following GR knockdown, with 3,530 differentially expressed genes (DEGs) in BMSCs and 4,657 in primary osteoblasts. Despite substantial differences in gene expression profiles of the two osteogenic cell models, pathway enrichment analyses revealed common biological processes, including MAPK signaling and cell migration. Comparative transcriptomic analysis further identified only 17 genes that were consistently regulated in the same direction in both cell preparations, among which Map7d2 emerged as a previously unrecognized GR-responsive candidate. Combined depletion of GR and Map7d2 partially restored cellular Alp activity and the expression of selected osteogenic markers compared with GR depletion alone. Western blot analysis further showed restoration of Erk2 phosphorylation and Alp protein expression following combined GR and Map7d2 depletion, demonstrating an association between the partial rescue of selected osteogenic readouts and restoration of Erk2 signaling. Together, these findings identify Map7d2 as a previously unrecognized GR-responsive candidate associated with Erk2 signaling and osteogenic differentiation. Our study reveals common molecular responses to GR depletion across two primary murine osteogenic cell models and provides new insights into the transcriptional and signaling networks underlying GR-regulated osteogenic differentiation.
- Open Access
- 30 August 2026
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 10 (10)
Identification of candidate receptors mediating the osteoanabolic influence of Wnt1
Although WNT signaling pathways are of central importance for osteoblast regulation, Wnt1 is the only known ligand for which an osteoanabolic function has been demonstrated based on human genetic evidence. The therapeutic potential of Wnt1 was further documented in a transgenic model allowing inducible Wnt1 expression in osteoblasts, which produced a marked increase in trabecular and cortical bone mass within three weeks. However, the molecular mechanisms and target cells of Wnt1 action remain unclear. In this study, we analyzed transgenic mice with Wnt1 induction for 3, 5, or 7 d and confirmed rapid osteoanabolic effects in the spine and tibia. We also observed strong recruitment of osteoblasts and progenitor cells to bone surfaces. Cell culture experiments revealed that Wnt1 primarily acts on mesenchymal progenitor cells, as only the mesenchymal cell line ST2, not MC3T3-E1 osteoblasts, responded to Wnt1. Comparing receptor expression between these lines identified several Fzd genes, including Fzd4, with higher expression in ST2 cells. Knockdown by siRNA confirmed that FZD4, together with LRP5 and LRP6, mediates Wnt1-responsiveness in ST2 cells. Although Fzd4 deletion did not impair the in vivo anabolic effects of Wnt1 overexpression, Fzd4-heterozygous mice displayed moderately reduced bone mass at 24 wk. These findings demonstrate that Wnt1 strongly influences mesenchymal osteoprogenitor cells and identify FZD4 as one candidate receptor mediating these effects.
- 30 August 2026
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 10 (10)
Open AccessIdentification of candidate receptors mediating the osteoanabolic influence of Wnt1
Although WNT signaling pathways are of central importance for osteoblast regulation, Wnt1 is the only known ligand for which an osteoanabolic function has been demonstrated based on human genetic evidence. The therapeutic potential of Wnt1 was further documented in a transgenic model allowing inducible Wnt1 expression in osteoblasts, which produced a marked increase in trabecular and cortical bone mass within three weeks. However, the molecular mechanisms and target cells of Wnt1 action remain unclear. In this study, we analyzed transgenic mice with Wnt1 induction for 3, 5, or 7 d and confirmed rapid osteoanabolic effects in the spine and tibia. We also observed strong recruitment of osteoblasts and progenitor cells to bone surfaces. Cell culture experiments revealed that Wnt1 primarily acts on mesenchymal progenitor cells, as only the mesenchymal cell line ST2, not MC3T3-E1 osteoblasts, responded to Wnt1. Comparing receptor expression between these lines identified several Fzd genes, including Fzd4, with higher expression in ST2 cells. Knockdown by siRNA confirmed that FZD4, together with LRP5 and LRP6, mediates Wnt1-responsiveness in ST2 cells. Although Fzd4 deletion did not impair the in vivo anabolic effects of Wnt1 overexpression, Fzd4-heterozygous mice displayed moderately reduced bone mass at 24 wk. These findings demonstrate that Wnt1 strongly influences mesenchymal osteoprogenitor cells and identify FZD4 as one candidate receptor mediating these effects.
- Open Access
- 11 August 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (39) , e71574
Dynamic Loading Regulates Meniscus‐Like Matrix Production in Human Mesenchymal Stromal Cell‐Seeded PET Scaffolds
Meniscal injury is a leading cause of early‐onset osteoarthritis, yet regenerative options remain limited. This study investigates a nonwoven polyethylene terephthalate (PET) scaffold for meniscus tissue engineering and assesses its capacity to support mesenchymal stromal cell (MSC) proliferation and chondrogenic differentiation under dynamic loading. Human MSCs are seeded onto PET scaffolds (400–420 g/m 2 , 85% porosity) and cultured for up to 21 days under basal medium (Ctr), chondrogenic differentiation conditions (ChD), or ChD combined with dynamic loading (ChD + Dyn, 12% strain, 1 Hz, 1 h/day, 5 days/week). PET scaffolds support uniform MSC adhesion and colonization. Compared with ChD alone, ChD+Dyn significantly increases cell proliferation and transiently upregulated chondrogenic markers ( SOX9 , ACAN , COL1A1 , COL2A1 ) while suppressing the hypertrophic marker COL10A1 . Although collagen deposition and construct biomechanics remained unchanged over 21 days, glycosaminoglycan accumulation was reduced in the ChD + Dyn group compared with ChD. RNA sequencing revealed distinct mechanosensitive transcriptional signatures induced by dynamic loading, particularly in genes associated with extracellular matrix remodeling, mechanotransduction, and developmental signaling pathways. These findings demonstrate that nonwoven PET provides a mechanically robust scaffold for meniscus tissue engineering and that dynamic loading promotes MSC proliferation while transiently regulating chondrogenic differentiation and mechanoadaptive matrix remodeling toward a meniscus‐like phenotype.
- 11 August 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (39) , e71574
Open AccessDynamic Loading Regulates Meniscus‐Like Matrix Production in Human Mesenchymal Stromal Cell‐Seeded PET Scaffolds
Meniscal injury is a leading cause of early‐onset osteoarthritis, yet regenerative options remain limited. This study investigates a nonwoven polyethylene terephthalate (PET) scaffold for meniscus tissue engineering and assesses its capacity to support mesenchymal stromal cell (MSC) proliferation and chondrogenic differentiation under dynamic loading. Human MSCs are seeded onto PET scaffolds (400–420 g/m 2 , 85% porosity) and cultured for up to 21 days under basal medium (Ctr), chondrogenic differentiation conditions (ChD), or ChD combined with dynamic loading (ChD + Dyn, 12% strain, 1 Hz, 1 h/day, 5 days/week). PET scaffolds support uniform MSC adhesion and colonization. Compared with ChD alone, ChD+Dyn significantly increases cell proliferation and transiently upregulated chondrogenic markers ( SOX9 , ACAN , COL1A1 , COL2A1 ) while suppressing the hypertrophic marker COL10A1 . Although collagen deposition and construct biomechanics remained unchanged over 21 days, glycosaminoglycan accumulation was reduced in the ChD + Dyn group compared with ChD. RNA sequencing revealed distinct mechanosensitive transcriptional signatures induced by dynamic loading, particularly in genes associated with extracellular matrix remodeling, mechanotransduction, and developmental signaling pathways. These findings demonstrate that nonwoven PET provides a mechanically robust scaffold for meniscus tissue engineering and that dynamic loading promotes MSC proliferation while transiently regulating chondrogenic differentiation and mechanoadaptive matrix remodeling toward a meniscus‐like phenotype.
- Open Access
- 6 July 2026
- Published by Springer Nature in Bone Research
- Vol. 14 (1) , 71
Inhibition of AXL receptor tyrosine kinase increases osteoblast function and bone mass
Osteoporosis, a prevalent age-related disease, is characterized by impaired bone formation and an increased risk of fractures. Current anabolic treatments primarily rely on biologics, which are costly and require inconvenient administration. Identifying regulators of osteoblastogenesis that are amenable to small-molecule targeting is essential for developing more accessible therapies. Through an unbiased kinome-wide RNAi screen in primary murine calvarial osteoblasts, we identified the AXL receptor tyrosine kinase (Axl) as a negative regulator of osteoblast differentiation. Axl is most highly expressed in undifferentiated and early differentiated osteoblasts, with a rapid decline in expression during osteoblast maturation. siRNA-mediated knockdown of Axl or pharmacological inhibition with the small molecule BGB324 significantly enhanced osteoblast differentiation and mineralization in vitro. In mice, BGB324 treatment significantly increased bone mass by promoting bone formation. Mechanistically, Axl knockdown or inhibition upregulated interferon-stimulated gene 15 (Isg15) , while Isg15 knockdown impaired osteoblast differentiation and enhanced Erk phosphorylation, leading to increased expression of osteoblast-specific genes. Consistently, double knockdown experiments demonstrated that simultaneous loss of Axl with either Isg15 or Mapk1 , but not other interferon-related genes, reversed the Axl knockdown-induced increase in osteoblast differentiation, reinforcing their mechanistic involvement. Collectively, our study identifies Axl as a promising therapeutic target for osteoporosis and other bone-related disorders.
- 6 July 2026
- Published by Springer Nature in Bone Research
- Vol. 14 (1) , 71
Open AccessInhibition of AXL receptor tyrosine kinase increases osteoblast function and bone mass
Osteoporosis, a prevalent age-related disease, is characterized by impaired bone formation and an increased risk of fractures. Current anabolic treatments primarily rely on biologics, which are costly and require inconvenient administration. Identifying regulators of osteoblastogenesis that are amenable to small-molecule targeting is essential for developing more accessible therapies. Through an unbiased kinome-wide RNAi screen in primary murine calvarial osteoblasts, we identified the AXL receptor tyrosine kinase (Axl) as a negative regulator of osteoblast differentiation. Axl is most highly expressed in undifferentiated and early differentiated osteoblasts, with a rapid decline in expression during osteoblast maturation. siRNA-mediated knockdown of Axl or pharmacological inhibition with the small molecule BGB324 significantly enhanced osteoblast differentiation and mineralization in vitro. In mice, BGB324 treatment significantly increased bone mass by promoting bone formation. Mechanistically, Axl knockdown or inhibition upregulated interferon-stimulated gene 15 (Isg15) , while Isg15 knockdown impaired osteoblast differentiation and enhanced Erk phosphorylation, leading to increased expression of osteoblast-specific genes. Consistently, double knockdown experiments demonstrated that simultaneous loss of Axl with either Isg15 or Mapk1 , but not other interferon-related genes, reversed the Axl knockdown-induced increase in osteoblast differentiation, reinforcing their mechanistic involvement. Collectively, our study identifies Axl as a promising therapeutic target for osteoporosis and other bone-related disorders.
- 8 September 2025
- Published by British Editorial Society of Bone & Joint Surgery in Orthopaedic Proceedings
- Vol. 107-B (SUPP_6) , 60
THE WNT1G177C/G177C MUTATION IMPAIRS FRACTURE HEALING IN MICE
Wnt1 is essential for bone development and remodeling, with pathogenic variants associated with osteogenesis imperfecta type XV (OI-XV) and early-onset osteoporosis (EOOP) in humans and mice. However, the impact of Wnt1 variants on fracture healing remains unclear. This study investigates how the Wnt1G177C/G177C variant, associated with OI in humans, affects fracture repair processes, including inflammation, bone formation, and remodeling.A standardized femur osteotomy was performed in 12-week-old female Wnt1+/+ and Wnt1G177C/G177C mice, stabilized using an external fixator. At day 21 post-fracture, three-point bending test assessed the mechanical properties of fractured and unfractured femora. Bone quality was analyzed using microcomputed tomography (µCT), and histomorphometric analysis of the fracture callus was conducted on day 10. Early inflammatory responses, including immune cell populations, chemokines, and cytokines, were quantified on day 2 post-fracture using flow cytometry and a 36-plex cytokine/chemokine assay.Wnt1G177C/G177C mice exhibited significantly reduced mechanical strength (N.mm2) in unfractured (2688.4±486.7 vs 1660.3±350.3, P < 0.001) and fractured femora (1358.3±645.0 vs 439.3±257.5, P < 0.01) compared to Wnt1+/+ controls. µCT revealed decreased cortical thickness (µm) in unfractured femora (204.7±13.1 vs 163.5±9.5, P < 0.001) and reduced bone volume fraction (%) in the fracture callus of Wnt1G177C/G177C mice (12.1±3.9 vs 6.9±2.8, P < 0.05) Histomorphometric analysis showed increased cartilage area (%) (14.1±4.4 vs 22.0±5.9, P < 0.05) and a trend towards reduced bone area (%) within the fracture callus (13.4±3.4 vs 8.7±4.5, P = 0.06) The early inflammatory phase was compromised in Wnt1G177C/G177C mice, evidenced by reduced macrophage numbers and lower levels of chemokines CCL5 and CCL7The Wnt1G177C/G177C variant impairs bone repair by disrupting bone formation and the inflammatory response critical for effective healing. Targeting Wnt1 signaling pathways presents a promising therapeutic approach to improve fracture repair in Wnt1-related bone disorders and other conditions with compromised bone healing.
- 8 September 2025
- Published by British Editorial Society of Bone & Joint Surgery in Orthopaedic Proceedings
- Vol. 107-B (SUPP_6) , 60
THE WNT1G177C/G177C MUTATION IMPAIRS FRACTURE HEALING IN MICE
Wnt1 is essential for bone development and remodeling, with pathogenic variants associated with osteogenesis imperfecta type XV (OI-XV) and early-onset osteoporosis (EOOP) in humans and mice. However, the impact of Wnt1 variants on fracture healing remains unclear. This study investigates how the Wnt1G177C/G177C variant, associated with OI in humans, affects fracture repair processes, including inflammation, bone formation, and remodeling.A standardized femur osteotomy was performed in 12-week-old female Wnt1+/+ and Wnt1G177C/G177C mice, stabilized using an external fixator. At day 21 post-fracture, three-point bending test assessed the mechanical properties of fractured and unfractured femora. Bone quality was analyzed using microcomputed tomography (µCT), and histomorphometric analysis of the fracture callus was conducted on day 10. Early inflammatory responses, including immune cell populations, chemokines, and cytokines, were quantified on day 2 post-fracture using flow cytometry and a 36-plex cytokine/chemokine assay.Wnt1G177C/G177C mice exhibited significantly reduced mechanical strength (N.mm2) in unfractured (2688.4±486.7 vs 1660.3±350.3, P < 0.001) and fractured femora (1358.3±645.0 vs 439.3±257.5, P < 0.01) compared to Wnt1+/+ controls. µCT revealed decreased cortical thickness (µm) in unfractured femora (204.7±13.1 vs 163.5±9.5, P < 0.001) and reduced bone volume fraction (%) in the fracture callus of Wnt1G177C/G177C mice (12.1±3.9 vs 6.9±2.8, P < 0.05) Histomorphometric analysis showed increased cartilage area (%) (14.1±4.4 vs 22.0±5.9, P < 0.05) and a trend towards reduced bone area (%) within the fracture callus (13.4±3.4 vs 8.7±4.5, P = 0.06) The early inflammatory phase was compromised in Wnt1G177C/G177C mice, evidenced by reduced macrophage numbers and lower levels of chemokines CCL5 and CCL7The Wnt1G177C/G177C variant impairs bone repair by disrupting bone formation and the inflammatory response critical for effective healing. Targeting Wnt1 signaling pathways presents a promising therapeutic approach to improve fracture repair in Wnt1-related bone disorders and other conditions with compromised bone healing.
- Open Access
- 7 October 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (19) , e70076
Inflammatory priming of human mesenchymal stem cells induces osteogenic differentiation via the early response gene IER3
Mesenchymal stem cells (MSCs) have gained tremendous interest due to their overall potent pro‐regenerative and immunomodulatory properties. In recent years, various in vitro and preclinical studies have investigated different priming (“licensing”) approaches to enhance MSC functions for specific therapeutic purposes. In this study, we primed bone marrow‐derived human MSCs (hMSCs) with an inflammation cocktail designed to mimic the elevated levels of inflammatory mediators found in serum of patients with severe injuries, such as bone fractures. We observed a significantly enhanced osteogenic differentiation potential of primed hMSCs compared to untreated controls. By RNA‐sequencing analysis, we identified the immediate early response 3 ( IER3 ) gene as one of the top‐regulated genes upon inflammatory priming. Small interfering RNA knockdown experiments established IER3 as a novel positive regulator of osteogenic differentiation. Mechanistic analysis further revealed that IER3 deletion significantly downregulated bone marrow stromal cell antigen 2 (BST2) expression and extracellular signal‐related kinase 1/2 (ERK1/2) phosphorylation in hMSCs, suggesting that IER3 regulates osteogenic differentiation through BST2 and ERK1/2 signaling pathway activation. On the basis of these findings, we propose IER3 as a novel therapeutic target to promote hMSC osteoblastogenesis, which might be of high clinical relevance, for example, in patients with osteoporosis or compromised fracture healing.
- 7 October 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (19) , e70076
Open AccessInflammatory priming of human mesenchymal stem cells induces osteogenic differentiation via the early response gene IER3
Mesenchymal stem cells (MSCs) have gained tremendous interest due to their overall potent pro‐regenerative and immunomodulatory properties. In recent years, various in vitro and preclinical studies have investigated different priming (“licensing”) approaches to enhance MSC functions for specific therapeutic purposes. In this study, we primed bone marrow‐derived human MSCs (hMSCs) with an inflammation cocktail designed to mimic the elevated levels of inflammatory mediators found in serum of patients with severe injuries, such as bone fractures. We observed a significantly enhanced osteogenic differentiation potential of primed hMSCs compared to untreated controls. By RNA‐sequencing analysis, we identified the immediate early response 3 ( IER3 ) gene as one of the top‐regulated genes upon inflammatory priming. Small interfering RNA knockdown experiments established IER3 as a novel positive regulator of osteogenic differentiation. Mechanistic analysis further revealed that IER3 deletion significantly downregulated bone marrow stromal cell antigen 2 (BST2) expression and extracellular signal‐related kinase 1/2 (ERK1/2) phosphorylation in hMSCs, suggesting that IER3 regulates osteogenic differentiation through BST2 and ERK1/2 signaling pathway activation. On the basis of these findings, we propose IER3 as a novel therapeutic target to promote hMSC osteoblastogenesis, which might be of high clinical relevance, for example, in patients with osteoporosis or compromised fracture healing.
- Open Access
- 26 February 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (4) , e23489
Mechanical induction of osteoanabolic Wnt1 promotes osteoblast differentiation via Plat
Physical activity‐induced mechanical stimuli play a crucial role in preserving bone mass and structure by promoting bone formation. While the Wnt pathway is pivotal for mediating the osteoblast response to loading, the exact mechanisms are not fully understood. Here, we found that mechanical stimulation induces osteoblastic Wnt1 expression, resulting in an upregulation of key osteogenic marker genes, including Runx2 and Sp7 , while Wnt1 knockdown using siRNA prevented these effects. RNAseq analysis identified Plat as a major target through which Wnt1 exerts its osteogenic influence. This was corroborated by Plat depletion using siRNA, confirming its positive role in osteogenic differentiation. Moreover, we demonstrated that mechanical stimulation enhances Plat expression, which, in turn leads to increased expression of osteogenic markers like Runx2 and Sp7 . Notably, Plat depletion by siRNA prevented this effect. We have established that Wnt1 regulates Plat expression by activating β‐Catenin. Silencing Wnt1 impairs mechanically induced β‐Catenin activation, subsequently reducing Plat expression. Furthermore, our findings showed that Wnt1 is essential for osteoblasts to respond to mechanical stimulation and induce Runx2 and Sp7 expression, in part through the Wnt1/β‐Catenin/Plat signaling pathway. Additionally, we observed significantly reduced Wnt1 and Plat expression in bones from ovariectomy (OVX)‐induced and age‐related osteoporotic mouse models compared with non‐OVX and young mice, respectively. Overall, our data suggested that Wnt1 and Plat play significant roles in mechanically induced osteogenesis. Their decreased expression in bones from OVX and aged mice highlights their potential involvement in post‐menopausal and age‐related osteoporosis, respectively.
- 26 February 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (4) , e23489
Open AccessMechanical induction of osteoanabolic Wnt1 promotes osteoblast differentiation via Plat
Physical activity‐induced mechanical stimuli play a crucial role in preserving bone mass and structure by promoting bone formation. While the Wnt pathway is pivotal for mediating the osteoblast response to loading, the exact mechanisms are not fully understood. Here, we found that mechanical stimulation induces osteoblastic Wnt1 expression, resulting in an upregulation of key osteogenic marker genes, including Runx2 and Sp7 , while Wnt1 knockdown using siRNA prevented these effects. RNAseq analysis identified Plat as a major target through which Wnt1 exerts its osteogenic influence. This was corroborated by Plat depletion using siRNA, confirming its positive role in osteogenic differentiation. Moreover, we demonstrated that mechanical stimulation enhances Plat expression, which, in turn leads to increased expression of osteogenic markers like Runx2 and Sp7 . Notably, Plat depletion by siRNA prevented this effect. We have established that Wnt1 regulates Plat expression by activating β‐Catenin. Silencing Wnt1 impairs mechanically induced β‐Catenin activation, subsequently reducing Plat expression. Furthermore, our findings showed that Wnt1 is essential for osteoblasts to respond to mechanical stimulation and induce Runx2 and Sp7 expression, in part through the Wnt1/β‐Catenin/Plat signaling pathway. Additionally, we observed significantly reduced Wnt1 and Plat expression in bones from ovariectomy (OVX)‐induced and age‐related osteoporotic mouse models compared with non‐OVX and young mice, respectively. Overall, our data suggested that Wnt1 and Plat play significant roles in mechanically induced osteogenesis. Their decreased expression in bones from OVX and aged mice highlights their potential involvement in post‐menopausal and age‐related osteoporosis, respectively.
- Open Access
- 4 July 2023
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 38 (8) , 1045-1061
Why Animal Experiments Are Still Indispensable in Bone Research: A Statement by the European Calcified Tissue Society
Major achievements in bone research have always relied on animal models and in vitro systems derived from patient and animal material. However, the use of animals in research has drawn intense ethical debate and the complete abolition of animal experimentation is demanded by fractions of the population. This phenomenon is enhanced by the reproducibility crisis in science and the advance of in vitro and in silico techniques. 3D culture, organ‐on‐a‐chip, and computer models have improved enormously over the last few years. Nevertheless, the overall complexity of bone tissue cross‐talk and the systemic and local regulation of bone physiology can often only be addressed in entire vertebrates. Powerful genetic methods such as conditional mutagenesis, lineage tracing, and modeling of the diseases enhanced the understanding of the entire skeletal system. In this review endorsed by the European Calcified Tissue Society (ECTS), a working group of investigators from Europe and the US provides an overview of the strengths and limitations of experimental animal models, including rodents, fish, and large animals, as well the potential and shortcomings of in vitro and in silico technologies in skeletal research. We propose that the proper combination of the right animal model for a specific hypothesis and state‐of‐the‐art in vitro and/or in silico technology is essential to solving remaining important questions in bone research. This is crucial for executing most efficiently the 3R principles to reduce, refine, and replace animal experimentation, for enhancing our knowledge of skeletal biology, and for the treatment of bone diseases that affect a large part of society. © 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
- 4 July 2023
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 38 (8) , 1045-1061
Open AccessWhy Animal Experiments Are Still Indispensable in Bone Research: A Statement by the European Calcified Tissue Society
Major achievements in bone research have always relied on animal models and in vitro systems derived from patient and animal material. However, the use of animals in research has drawn intense ethical debate and the complete abolition of animal experimentation is demanded by fractions of the population. This phenomenon is enhanced by the reproducibility crisis in science and the advance of in vitro and in silico techniques. 3D culture, organ‐on‐a‐chip, and computer models have improved enormously over the last few years. Nevertheless, the overall complexity of bone tissue cross‐talk and the systemic and local regulation of bone physiology can often only be addressed in entire vertebrates. Powerful genetic methods such as conditional mutagenesis, lineage tracing, and modeling of the diseases enhanced the understanding of the entire skeletal system. In this review endorsed by the European Calcified Tissue Society (ECTS), a working group of investigators from Europe and the US provides an overview of the strengths and limitations of experimental animal models, including rodents, fish, and large animals, as well the potential and shortcomings of in vitro and in silico technologies in skeletal research. We propose that the proper combination of the right animal model for a specific hypothesis and state‐of‐the‐art in vitro and/or in silico technology is essential to solving remaining important questions in bone research. This is crucial for executing most efficiently the 3R principles to reduce, refine, and replace animal experimentation, for enhancing our knowledge of skeletal biology, and for the treatment of bone diseases that affect a large part of society. © 2023 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
- Open Access
- 15 December 2022
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 7 (2) , e10711
Downregulation of the Autism Spectrum Disorder Gene Shank2 Decreases Bone Mass in Male Mice
Mutations of the postsynaptic scaffold protein Shank2 lead to autism spectrum disorders (ASD). These patients frequently suffer from higher fracture risk. Here, we investigated whether Shank2 directly regulates bone mass. We show that Shank2 is expressed in bone and that Shank2 levels are increased during osteoblastogenesis. Knockdown of Shank2 by siRNA targeting the encoding regions for PDZ and SAM domain inhibits osteoblastogenesis of primary murine calvarial osteoblasts. Shank2 knockout mice (Shank2−/−) have a decreased bone mass due to reduced osteoblastogenesis and bone formation, whereas bone resorption remains unaffected. Induced pluripotent stem cells (iPSCs)‐derived osteoblasts from a loss‐of‐function Shank2 mutation in a patient showed a significantly reduced osteoblast differentiation potential. Moreover, silencing of known Shank2 interacting proteins revealed that a majority of them promote osteoblast differentiation. From this we conclude that Shank2 and interacting proteins known from the central nervous system are decisive regulators in osteoblast differentiation. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
- 15 December 2022
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 7 (2) , e10711
Open AccessDownregulation of the Autism Spectrum Disorder Gene Shank2 Decreases Bone Mass in Male Mice
Mutations of the postsynaptic scaffold protein Shank2 lead to autism spectrum disorders (ASD). These patients frequently suffer from higher fracture risk. Here, we investigated whether Shank2 directly regulates bone mass. We show that Shank2 is expressed in bone and that Shank2 levels are increased during osteoblastogenesis. Knockdown of Shank2 by siRNA targeting the encoding regions for PDZ and SAM domain inhibits osteoblastogenesis of primary murine calvarial osteoblasts. Shank2 knockout mice (Shank2−/−) have a decreased bone mass due to reduced osteoblastogenesis and bone formation, whereas bone resorption remains unaffected. Induced pluripotent stem cells (iPSCs)‐derived osteoblasts from a loss‐of‐function Shank2 mutation in a patient showed a significantly reduced osteoblast differentiation potential. Moreover, silencing of known Shank2 interacting proteins revealed that a majority of them promote osteoblast differentiation. From this we conclude that Shank2 and interacting proteins known from the central nervous system are decisive regulators in osteoblast differentiation. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
- Open Access
- 15 June 2022
- Published by Elsevier in Bone Reports
- Vol. 16, 101292
Cdk5 ablation in osteoblast lineage increases osteocyte apoptosis in mice
- 15 June 2022
- Published by Elsevier in Bone Reports
- Vol. 16, 101292
Open AccessCdk5 ablation in osteoblast lineage increases osteocyte apoptosis in mice